• No results found

Detection of a broad range of Leishmania species and determination of parasite load of infected mouse by real-time PCR targeting the arginine permease gene AAP3

N/A
N/A
Protected

Academic year: 2022

Share "Detection of a broad range of Leishmania species and determination of parasite load of infected mouse by real-time PCR targeting the arginine permease gene AAP3"

Copied!
6
0
0

Laster.... (Se fulltekst nå)

Fulltekst

(1)

ContentslistsavailableatScienceDirect

Acta Tropica

j ou rn a l h o m epa g e :w w w . e l s e v i e r . c o m / l o c a t e / a c t a t r o p i c a

Detection of a broad range of Leishmania species and determination of parasite load of infected mouse by real-time PCR targeting the

arginine permease gene AAP3

Marit Gjerde Tellevik

a,∗

, Karl Erik Muller

b

, Karen Rebbestad Løkken

b

, Audun Helge Nerland

b

aNationalCentreforTropicalInfectiousDiseases,DepartmentofMedicine,HaukelandUniversityHospital,5021Bergen,Norway

bDepartmentofClinicalScience,UniversityofBergen,5021Bergen,Norway

a r t i c l e i n f o

Articlehistory:

Received19November2013 Receivedinrevisedform13May2014 Accepted14May2014

Availableonline22May2014

Keywords:

Leishmania qPCR

Argininepermease AAP3

Quantification Detection

a b s t r a c t

Leishmaniasisisoneoftheworld’smostneglectedinfectiousdiseases,affectingaround12millionpeople andmorethan350millionatriskofinfection.Theclinicalpicturevariesfromself-healingcutaneous lesionstoseverevisceralinfections,butstillnocommercialvaccinesforhumansareavailableandthe currentlyuseddrugshaveunpleasantsideeffects.Herewereportareal-timePCRassaytargetingthe argininepermeasegeneAAP3thatcanbeappliedforalltheninedifferentspeciesoftheLeishmania genustested;4OldWorldspeciesand5NewWorldspecies,frombothL.(Leishmania)andL.(Viannia) subgenera.Nocross-reactionwasseenwithTrypanosomacruzi,Trypanosomabrucei,humanormouse genomicDNA.Theassayhasahighsensitivity,withalimitofdetectionof10fgDNAforL.(L.)majorand L.(L.)donovani,and100fgDNAforL.(V.)braziliensis,andcanbeusedforbothqualitativeandquantitative purposes.ThisAAP3-Assay,runinduplexwithahostspecificgene-assay,wasalsosuccessfullyusedfor quantificationofparasiteloadoffootpadsfromL.(L.)major-infectedmice.Itcanthereforebeavaluable toolinapplicationslikemonitoringeffectsofdrugs,theselectionofvaccinecandidatesandinscreening patients,includingasymptomaticcarriers.

©2014TheAuthors.PublishedbyElsevierB.V.ThisisanopenaccessarticleundertheCCBY-NC-ND license(http://creativecommons.org/licenses/by-nc-nd/3.0/).

1. Introduction

Leishmaniasisisavector-bornediseasewithdifferentclinical picturescausedbyprotozoaofthegenusLeishmania.Itisoneofthe world’smostneglectedinfectiousdiseasesandthesecondcauseof parasiterelateddeathsaftermalaria(Mathersetal.,2007).Spread oftheLeishmaniaparasiteiscausedbythebiteofinfectedsand flies. Worldwidemore than350million peoplein 98 countries orterritoriesareatrisk(WorldHealthOrganization,2010).The estimatedincidenceofnewcaseseachyearis0.2–0.4millionfor visceralleishmaniasisand0.7–1.2millionforcutaneousleishman- iasis,causing20000to40000deathsannually,andthesedataare probablyunderestimates(Alvaretal.,2012).Insomeaffectedareas bothdomesticandsylvaticanimalsseemtobeimportantreservoirs oftheparasite,contributingtopromotehumaninfections(Quinnell

Correspondingauthor.Tel.:+4755977888.

E-mailaddresses:[email protected](M.G.Tellevik), [email protected](K.E.Muller),[email protected](K.R.Løkken), [email protected](A.H.Nerland).

andCourtenay,2009).Availabledrugsfortreatingthediseasecan becharacterizedaslimited,expensiveandoftenwithunpleasant sideeffects.Moreover,therehasbeenanemergenceofdrugresis- tance(SundarandChakravarty,2013).Nocommercialvaccinesare currentlyavailableforpreventingleishmaniasisinhumans.There- fore,inordertocontrolthedisease,thereisaneedfordevelopment ofnewdrugs,vaccinesandmorespecificandsensitivediagnostic methods.Assaysforquantificationoftheparasiteinthehosttis- suesareessentialfordevelopmentandtestingofprophylacticand therapeuticregimes.

Polymerase chain reaction (PCR) and its variations repre- sent highly sensitive and specific methods for Leishmania DNA detection.PCR hasshowntobesuperior toothermethods like microscopy andvarious immunologictests,reducing time from samplingtotestresult,optimizingsensitivityandspecificityand reducing subjective evaluation (Aviles et al., 1999; Bensoussan etal.,2006;Srivastavaetal.,2011a;Walletal.,2012).Real-time PCRis advantageousoverconventional PCRbecauseit isfaster, lesslabor-intensive,reducesriskofcontamination,andbyusing probesthesensitivityandspecificitycanbeincreased(Dymond, 2013; Mohammadiha et al., 2013; Yang and Rothman, 2004) http://dx.doi.org/10.1016/j.actatropica.2014.05.008

0001-706X/©2014TheAuthors.PublishedbyElsevierB.V.ThisisanopenaccessarticleundertheCCBY-NC-NDlicense(http://creativecommons.org/licenses/by-nc-nd/3.0/).

(2)

Furthermore,byusingstandardcurvesreal-timePCRcanbeused forquantification.ExploringtheLeishmaniaparasitesandtheclin- icalmanifestationstheycause,quantitativereal-timePCR(qPCR) canbeusefulfordetectionandspeciesidentification,butitalsohas awiderpotential,likemonitoringtheeffectofdrugactivityand measuringtheprotectionaspartofvaccinedevelopment.Dueto thehighsensitivity,qPCRcanbeusedforscreeningofpatientsand detectionofasymptomaticcarriers,andtherebyaddressinggaps intheunderstandingofinfectionwithLeishmania(Francinoetal., 2006;Maryetal.,2006;Pourabbasetal.,2013).

TherearemanypublicationsofdifferentvariantsofPCRsfor Leishmania,usingdifferentmoleculartargets,butmostprotocols target a single species (Francinoet al., 2006; Srivastava et al., 2011b), a group of closely related species (Harris et al., 1998;

Odiwuoretal.,2011),ortheyarenotquantitative(Berzunza-Cruz etal.,2009;deAlmeidaetal.,2011;Harrisetal.,1998;Odiwuor etal., 2011; Srivastavaet al., 2011b), and somealsoshow low sensitivity(Wortmannetal.,2005).Thereareonlyfewpublica- tionsof real-timePCR assaysthat targetallornearly allofthe approximately20 differentLeishmaniaspeciesfoundinhumans (Castilho etal.,2008; Tupperwaret al.,2008;Wortmannet al., 2001).Manyprotocolstargetmulticopygenes(Bossolascoetal., 2003;Francinoetal.,2006;Talmi-Franketal.,2010)andsomepro- tocolsformulticopygenesalsouseSYBRGreen(deMonbrisonetal., 2007).Multicopygenesareoftenpreferredtoenhancesensitivity, andthusareadvantageousfordetection,butduetopotentialvaria- tionsandinstabilityincopynumberofthesamegenebothbetween andwithinspecies(Weiratheretal.,2011)theycanbechallenging andconfoundingforquantificationusingstandardcurves.SYBR- Greenhasthedisadvantagesofmoreunspecificbinding,hencea probe,whichismorespecific,istobepreferred.However,itcan bechallengingtodesignaqPCRwithaspecificprobethattargeta DNAsequenceuniversaltoallspeciesoftheLeishmaniagenus.

l-ArginineisanessentialaminoacidforLeishmania,forwhich metabolismdependsonargininesupplyfromexternalsources,as noevidenceforendogenoussynthesishasbeenreported.Theargi- ninetransporterLeishmaniaargininepermeaseAAP3is encoded onchromosome31inLeishmania(L.)majorandotherLeishmania species,andonchromosome30inLeishmania(L.)mexicana(which

duetochromosomefusioneventsistheequivalentofchromosome 31inL.(L.)major(Brittoetal.,1998)).TheAAP3geneisidenti- fiedinseveraldifferentLeishmaniaspecies(Shaked-Mishanetal., 2006).LikelymoreAAP3sequenceswillbepublishedalongwith theincreasingnumberofsequencingprojects.

TheaimofthestudywastodevelopaquantitativePCRmethod thatcouldbeappliedforinfectivitystudiesinmice,focusingonL.

(L.)major,asmurinemodelsarewidelyusedinLeishmaniaresearch, withthebenefit thatitcouldalsobeusedforotherLeishmania species fromboth the Old-and New World groups. We devel- opedaPCR-AssaytargetingtheargininetransportergeneAAP3and includedDNAfromcellpelletsorculturedpromastigotesfromnine differentLeishmaniaspecies,aswellasdifferentnegativecontrols, tovalidatetheassay.ThisAAP3-Assay,runinduplexwithahost specificgene-assay,wasthenusedforquantificationofparasite loadoffootpadsfromL.(L.)major-infectedmice.

2. Materialsandmethods

2.1. Strainsusedinthisstudy

LeishmaniastrainsusedinthisstudyaregiveninTable1.Leish- maniapromastigotesweregrownat26CinRPMI1640medium (Sigma–Aldrich,StLouis,MO,USA)supplementedwith10%heat inactivated fetal calf serum (Gibco®, Life Technologies – Invi- trogen, Carlsbad, CA, USA), 100IU/ml penicillin and 100␮g/ml streptomycin, or in Schneider’s InsectMedium (Sigma–Aldrich) supplementedwith20%heatinactivatedfetalcalfserumand1%

sterile-filteredhumanurine.Parasitesinculturewerewashedand counted by flow cytometry using reference beads (Flow-Count Fluorospheres®, Beckman Coulter, Brea, CA, USA) after stain- ingwithVybrant® DyeCycleTMGreen Stain(Molecularprobes®, Eugene,OR,USA).

L.(L.)mexicanaMHOM/BZ/82/BEL21wasakindgiftfromCen- trodeInvestigacionesRegionales‘Dr.HideyoNoguchi’,Universidad AutónomadeYucatán,Mérida,Yucatán,México.Cellpelletsfrom Leishmania strainsas indicated inTable 1,as wellasfromTry- panosomabruceiandT.cruzi,werekindlydonatedfromDr.Silvia

Table1

Leishmaniastrainsusedinthisstudy,andtheirCq-valuewhen100pgofDNAwasusedastemplateintheAAP3-Assay.

Speciesa Internationalcodeorotherreference Origin Sourceb Cqc

L.(L.)aethiopica MHOM/ET/91/Kassaye Ethiopia SMI 23.4

L.(V.)amazonensis MHOM/BR/73/M2269,LEM0690 Brazil CNRL 23.7

L.(V.)braziliensis MHOM/BR/87/LTB12MAR87,LEM2839 Brazil CNRL 25.0

L.(V.)braziliensis MHOM/BR/75/M2904,LEM2249 Brazil CNRL 25.1

L.(V.)braziliensis SMI2094 Unknown SMI 25.3

L.(L.)donovani MHOM/CY/2006/CH33,LEM5298 Cyprus CNRL 23.8

L.(L.)donovani MHOM/IN/80/DD8,LEM0703 India CNRL 23.7

L.(L.)donovani MHOM/ET/67/HU3 Ethiopia SMI 23.7

L.(V.)guyanensis MHOM/GF/94/22319,LEM2763 FrenchGuiana CNRL 27.6

L.(L.)major MHOM/AF/2006/LEM5344,LEM5344 Afghanistan CNRL 23.9

L.(L.)major MHOM/MA/2004/LEM4905,LEM4905 Morocco CNRL 24.2

L.(L.)major MHOM/TN/2006/LPN296,LEM5373 Tunisia CNRL 23.9

L.(L.)major MHOM/IL/80/FRIEDLIN,LEM3150 Israel CNRL 23.4

L.(L.)major-np MRHO/SU/59/LV39 USSR CNRL 23.6

L.(L.)major-p MRHO/SU/59/LV39 USSR CNRL 24.0

L.(L.)mexicana MHOM/MX/96/NAN01,LEM3816 Mexico CNRL 23.8

L.(L.)mexicana MHOM/MX/93/CRE47,LEM2695 Mexico CNRL 23.5

L.(L.)mexicana-np MHOM/BZ/82/BEL21 Belize CIR 24.3

L.(L.)mexicana-p MHOM/BZ/82/BEL21 Belize CIR 24.4

L.(V.)naiffi MHOM/GF/97/CRE88,LEM3426 FrenchGuiana CNRL 24.0

L.(L.)tropica MHOM/SU/74/K27,LEM0419 USSR CNRL 24.2

L.(L.)tropica MHOM/MA/2000/INHW10,LEM5277 Morocco CNRL 24.1

anp:notbeenpropagatedinmouse;p:propagatedinmouse.

b SMI:PublicHealthAgencyofSweden,Sweden;CNRL:CentreNationaldeRéfèrencedesLeishmanioses,Montpellier,France;CIR:CentrodeInvestigacionesRegionales, UniversidadAutónomadeYucatán,Mérida,Yucatán.

c Cq-valuefromtheAAP3-assayusing100pgDNAastemplate.

(3)

Botero-KleivenandDr.LeighDavidssonatthePublicHealthAgency ofSweden,Sweden,andwerekeptinethanolduringtransportto ourlaboratoryanduntilDNAextraction.

2.2. DetectionoftheAAP3geneinLeishmaniaspecies 2.2.1. DNAextraction

Culturedpromastigotesfromthestationaryphaseandcellpel- letsinethanolwerewashedwithDulbecco’sphosphate-buffered saline(10mMPhosphate,137mMSodiumchloride,2.7mMPotas- siumchloride,pH7.4)(DPBS)beforesubjectedtoDNAextraction using QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions, except that Pro- teinaseKwasusedinsteadofprotease.DNAwaselutedin100␮lof BufferAE(Qiagen).InallDNAextractionsanegativecontrolofDPBS wasincludedtomonitorfor contamination.DNAconcentration andqualitywasdeterminedbyaNanoDrop®ND-1000Spectropho- tometer(ThermoScientific,Wilmington,DE,USA).AllDNAsamples werestoredat−20C.

2.2.2. Real-timePCR

Primersandhydrolysisprobe(TaqMan®MGBprobe)targeting a74bpregionoftheL.(L.)majorgeneencodingtheargininetrans- porterAAP3weredesignedbytheCustomTaqMan®AssayDesign ToolfromApplied Biosystems(AppliedBiosystems,Warrington, UK).Thesequencesoftheprimersand probewere5-GGCGGC- GGTATTATCTCGAT-3 (Forward), 5-ACCACGAGGTAGATGACAGA- CA-3(Reverse)andFAM5-ATGTCGGGCATCATC-3 NFQ(probe).

In silico analysis of specificity of the assay was performed using the Vector NTI software (Life Technologies). A global BLAST search was undertaken by the 74bp region wherein the primers and probe bind. In addition, complete genome sequences of some relevant bacteria (like Mycobacteria, Pseu- domonas, Streptococcus, Staphylococcus) were downloaded from GenBank (http://www.ncbi.nlm.nih.gov/genbank/) and investi- gatedfortheextentofbinding(BLAST)oftheprimersandprobe.

EachPCRtest wasperformedintriplicatein a20␮lreaction mixture.Thereactionmixtureincluded:1×TaqManUniversalMas- terMixIIwithUNG(AppliedBiosystems),1×CustomTaqMan® GeneExpressionAssayMixwithprimersandprobetargetingthe LeishmaniaAAP3gene,1×TaqMan®CopyNumberReferenceAssay, Mouse,Tfrc,waterand100pgofDNAsample.ThePCRwasrunasa duplexassayaftercomparingtheresultsofsingleplexAAP3-Assay andtheduplexwiththeTfrc-Assay(resultsnotshown).

TheqPCRwasperformedwithanAppliedBiosystems7900HT FastReal-TimePCRSystem(AppliedBiosystems),withcyclingcon- ditionsasfollows:50Cfor2min,95Cfor10min,followedby40 cyclesat95Cfor15sand60Cfor1mineach.Allsampleswere runonMicroAmp®Optical96-wellReactionPlates(AppliedBiosys- tems) sealed with MicroAmp® Optical Adhesive Film (Applied Biosystems). Each run included multiple no-template controls.

HumanDNA,T.bruceiandT.cruziwasusedasnegativecontrolsto checkforcross-reactivity.ThehumanDNAforcontrolwasprovided byChristelG.Haanshuus,NationalCentreforTropicalInfectious Diseases,DepartmentofMedicine,HaukelandUniversityHospital, Bergen,Norway.

Tenfold dilution series of L. (L.) major DNA (range 12ng–1.2×107ng)werepreparedforcreatingstandardcurves and estimating assay performance for theAAP3-Assay. Besides quantification,dilutionseriesandstandardcurveswereusedfor estimation of PCR efficiency, limit of quantification (LOQ) and limitofdetection(LOD).LOQandLODwerealsoestimatedforL.

(L.) donovaniand L. (V.)braziliensis. The dilutioncorresponding totheLOQwasthehighestdilutionusedforthestandardcurve.

For estimating repeatability and reproducibility,replicates of a DNAsamplefromthefootpadsofBALB/cmiceinfectedwithL.(L.)

majorparasiteswereused.DNAwasquantifiedusingtheAbsolute QuantificationAssay.Thresholdsweresetautomatically.Ampli- conswererunona2%agarosegel(SeaKemTM,Lonza,Rockland, ME,USA)with1XGelRedTM(Biotium,Hayward,CA,USA)tocheck forthecorrectsize.Replicateswithquantificationcycle(Cq)-value differingbymorethan0.3wereomitted.

Aunidirectionalworkflowpre-topost-qPCRwasenforced,and preparationofqPCRreactionmixture,DNApreparationsandqPCR werecarriedoutinfacilitiesphysicallyseparatefromeachother.

2.3. DetectionoftheAAP3geneinL.(L.)major-infectedmice 2.3.1. Mousetissuesamples

The left footpads of female BALB/c mice were inoculated with10␮lof106ml–1L.(L.)majorparasitesinstationaryphase.

After swelling and lesions had developed, 56 days post inocu- lation, mice were euthanized after first using Isoba vet. 100%

(Intervet/Schering-PloughAnimalHealth,IntervetDenmarkA/S, Denmark)foranesthesia.Footpadsofcontrolmice(2animals)and infectedmice(8animals),andliverforprovidingcontrolDNA,were harvestedandstoredat−80C.

2.3.2. Ethicalclearance

TheanimalexperimentswereapprovedbytheNationalAnimal ResearchAuthorityinNorwayandcarriedoutattheLaboratory AnimalFacility(AAALAC-accredited)attheUniversityofBergen, Bergen,Norway.

2.3.3. DNAextractionfrommicetissue

Mouse footpads were subjected for DNA extraction by a phenol-chloroform based protocol from Instituto Oswaldo Cruz, Rio de Janeiro, Brazil, available at http://clioc.fiocruz.br/

documents/mmp.pdf(LeishmaniasisEpidemiologyNetworkSouth America, 2009). DNA pellet was dissolved in 200␮l TE-buffer (10mMTris–HCl,1mMEDTA,pH8.0)andincubatedatroomtem- peratureovernight.Mouseliverswereincubatedovernightat56C inBufferATL(Qiagen)with2mg/mlProteinaseK(Qiagen),before subjectedtoDNAextractionusingQIAampDNAMiniKit(Qiagen) accordingtothemanufacturer’sinstructions.DNAwaselutedin 100␮lofBufferAE(Qiagen).

InallDNAextractionsanegativecontrolofDPBSwasincluded to monitor for contamination. DNA concentration and quality was determined by a NanoDrop® ND-1000 Spectrophotometer (ThermoScientific,Wilmington,DE,USA).AllDNAsampleswere storedat−20C.

2.3.4. Quantitativereal-timePCR

Inordertonormalizetheparasiteloadforamountofmousetis- sueDNA,andhenceovercomethepossiblequantificationerrors duetodifferentcuttingpointswhenharvestingthefootpads,the qPCR was run asa duplex-assay withthe AAP3-Assay and the TaqMan® CopyNumber ReferenceAssay, Mouse, Tfrc (Applied Biosystems,FosterCity,CA,USA),asareferenceassay.Thispre- madereactionmixtureconsistsofprimersandaVIC®dye-labeled TAMRATMprobewhichdetectsthesingle-copytransferrinreceptor gene(Tfrc)inthemousegenome.

EachqPCRtestwasperformedintriplicateina20␮lreaction mixture.ThereactionmixturewasasinSection2.2.2,exceptthat 100ngofDNAsamplewasusedastemplate.Initialdilutionexper- imentsshowedthatwith100ngofDNAthebackgroundlevel,or inhibition,wasnegligible.

Fivefold dilution series of BALB/c mouse DNA (range 1050ng–0.33ng) were prepared for creating standard curve and estimating assay performance for theTfrc-Assay. For esti- mating repeatability and reproducibility, replicates of a DNA sample from the footpads of BALB/c mice infected withL. (L.)

(4)

majorparasiteswereused.DNAwasquantifiedusingtheAbsolute Quantification Assay. Thresholds were set automatically. The parasiteloadin tissuesamples wasgivenas theratiobetween Leishmania DNA and genomic mouse DNA in the 100ng DNA appliedtoeachPCRreaction.SincetheamountofDNAcannotbe reliablyestimatedoutsidethelinearareaofthestandardcurve, theDNAquantityforsampleswithLeishmaniaDNAlessthanthe LOQwassettobeequaltoorlessthantheLOQ.Parallelswith Cq-valuedifferingbymorethan0.3wereomitted.

3. Results

3.1. SpecificityoftheAAP3-AssayandtheTfrc-Assay

TheprimersandprobefortheAAP3-Assayweredesignedfor L.(L.)major.We alsoexperimentallytested theability ofthese oligonucleotidestodetectotherdifferentLeishmaniaspecies,rep- resentingninedifferentspecies,eitherisolatedfromcellpelletsor culturedpromastigotes.L.(L.)aethiopica,L.(V.)amazonensis,L.(V.) braziliensis,L.(L.)donovani,L.(V.)guyanensis,L.(L.)major,L.(L.) mexicana,L.(V.)naiffiandL.(L.)tropicacouldallbeamplifiedwith theAAP3-Assay,asseenfromTable1.ThePCRresultedinampli- consofthecorrectsize,74bp,asvisualizedbygelelectrophoresis (resultsnotshown).NeithertheAAP3-Assay northeTfrc-Assay couldamplifyT.bruceiandT.cruzi,orgenomicDNAfromhumans ormice(AAP3-Assayonly).

TheglobalBLAST searchwiththe74bpregion(whereinthe primersandtheprobesbind)gaveonlyhitsindicatinggeneration ofpositivesignalsof theassaywhentargetingDNA fromLeish- maniaspecies. Likewise,investigation of the bacterial genomic sequencesdidnotrevealstrongbindingofanycombinationsof appliedprimersinawaythatwouldgenerateamplificationofany segmenttowhichtheprobewouldbind,andtherebygivingriseto apositivesignal.

3.2. SensitivityoftheAAP3-Assay

LODandLOQwereestimatedforL.(V.)braziliensis,L.(L.)dono- vaniandL.(L.)majorusingserialdilutionsofDNApurifiedfrom invitro cultivated parasites. Withtheappliedmethodused for DNAextraction,100fgcorrespondedto2parasites(p).ForL.(V.) braziliensis,L.(L.)donovaniandL.(L.)majortheLODs,giveninfg withnumberofparasiteswithourextractionmethodinbrackets, were:≥100fg(2p),≥10fg(0.2p)and≥10fg(0.2p),respectively.

TheLOQsforL.(V.)braziliensis,L.(L.)donovaniandL.(L.)majorwere

≥1000fg(20p),≥10fg(0.2p)and≥100fg(2p),respectively.

3.3. Assayperformance

From the DNA dilution series parameters of assay perfor- manceotherthansensitivitywascalculated.Fromrepeatedruns themeanslopesoftheAAP3-AssayandTfrc-Assaywere−3.205 (range−2.994to−3.305)and -3.193(range−3.083to−3.313), respectively.Efficiency,asdeterminedfromtheslopeandusing the formula E=101/slope−1, was 105.1% for the AAP3-Assay and 105.7% for the Tfrc-Assay. The correlation coefficient, R2, was 0.999 (range 0.996–0.999) for the AAP3-Assay and 0.997 (range0.996–0.999)fortheTfrc-Assay,andtheY-interceptwas 19.48(range18.26–20.85) fortheAAP3-Assayand31.83(range 31.43–32.11)fortheTfrc-Assay.ADNAsamplefromthefootpads ofBALB/cmiceinfectedwithL.(L.)majorparasiteswasusedfor estimatingrepeatabilityandreproducibility.Theintra-assaycoef- ficientofvariation(CV)fortheAAP3-Assay,calculatedfromDNA quantityofreplicates,wasforeachofthreeseparateruns0.0908, 0.0901and0.0882,respectively.FortheTfrc-Assaytheintra-assay CVwasforeachoftwoseparateruns0.0179and0.021.Inter-assay

Fig.1. AmplificationplotfortheAAP3-AssayandtheTfrc-Assay.Amplification curvesforDNAisolatedfromfootpadofuninfectedControlmouse(Control)and mouseinfectedwithL.(L.)major.

CV,calculatedfromDNAquantityofseparateruns,was0.052for theAAP3-Assayand0.059fortheTfrc-Assay.Theratioin100ng DNAbetweenquantityofL.(L.)majorDNA,asmeasuredbythe AAP3-Assay,andmouseDNA,asmeasuredbytheTfrc-Assay,was 3.22×104and3.25×104forthesamesampleontwoseparate runs.

No amplification of any of the no-template controls was detected.

3.4. EstimationofL.(L.)majorDNAinmicefootpads

Foranalyzing andquantification ofparasiteloadoffootpads fromL.(L.)major-infectedmice,theAAP3-Assaywasruninduplex with a host specific gene-assay; the Tfrc-Assay, which detects mouseDNA.LeishmaniaDNAwassuccessfullyamplifiedfromall theinfected mice,but not from thecontrolmice. Fig.1 shows amplificationplotsfortheAAP3-AssayandtheTfrc-Assaywhen analyzinga sample ofLeishmania-infectedtissue,together with plotsfortheTfrc-Assaywhenanalyzingacontrolsampleofunin- fectedtissue.AsthemiceDNAconstitutethemajorityoftheDNA intheinfectedtissue,allplotsfromtheTfrc-Assaymakeupacon- currentcurve.ValuesfortheAAP3-Assaytriplicates andforthe triplicatesoftheTfrc-AssayaregiveninTable2.Inaddition,DNA isolatedfromthefootpadofoneoftheotherL.(L.)major-infected micewasanalyzed,wherewemadetwodifferentdilutionsofthe DNAtoconfirmthatthesameratiobetweenLeishmaniaDNAand mouseDNAwouldstillbeobtained.For148.5ngsampletheratio was1.99×104andusing74.3ngofthesamesampletheratiowas 1.93×104.

4. Discussion

Microscopy has traditionally been the cheapest and easiest methodfor detectingand counting,Leishmania parasites. How- ever,real-time PCR issuperior regarding sensitivity,specificity, capacityandhasinadditionshorttimeofanalysisandminimized subjectivityoflaboratorystaff.WehavedevelopedaqPCRassay abletodetectaslittleas10fgofDNA,andtoquantifydownto thelimit of 10fg(L.(L.)donovani).The AAP3-Assayis effective in detecting several different species, and possibly the species rangeforourassayisbroaderthanwehavetestedfor.Regarding specificity,bothexperimentalandbioinformaticanalyzesshowno homologyofthetargetsequencetonon-Leishmaniasequences.

(5)

Table2

QuantificationofL.(L.)majorDNAinfootpadfromexperimentalinfectedmouse.

Samplea CqAAP3-Assayb,c QtyLeishDNAd CqTfrc-Assayb QtymouseDNAe QtyLeishDNA/QtymouseDNA

L.(L.)major-1 28.08 2.3×10−3 25.55 90.03 2.55×10−5

L.(L.)major-2 27.96 2.5×10−3 25.46 96.18 2.60×10−5

L.(L.)major-3 28.03 2.4×10−3 25.46 95.99 2.50×10−5

Control1-1 Undet. 25.46 95.79

Control1-2 Undet. 25.51 92.54

Control1-3 Undet. 25.49 93.84

aControl1,uninfectedmice;resultsareshownforalltriplicatesforeachsample.

bCq,quantificationcycle.

c Undet.,Undetermined.

d QtyLeishDNA,QuantityLeishmaniaDNAinngdetectedbytheAAP3-Assayper100ngDNA.

eQtymouseDNA,QuantitymouseDNAinngdetectedbytheTfrc-Assayper100ngDNA.

WiththeappliedmethodusedforDNAextraction,100fgcor- respondedto2 parasites. Assuming 80fgof Leishmania DNA is equivalenttooneparasite,then100fgcorrespondsto1.2parasites, indicatingthatthesensitivityoftheAAP3-Assayactuallyisbetter thanexperienced,andcanbefurtherimprovedbyoptimizingDNA extraction.

RegardingsensitivityintermsofDNAquantity,theLODofour assayequalsthatofsomeofthepublicationstargetingbothrRNA- andkDNA minicirclegenes (Berzunza-Cruz etal.,2009; Nicolas etal.,2002; Prinaetal.,2007; Gomeset al.,2012;Talmi-Frank etal.,2010;Wortmannetal.,2001), whicharegeneswithhigh copynumbers,buttherearealsopublicationstargetingmulticopy genesshowinghighersensitivity(Francinoetal.,2006).However, whenusingmulticopygenesforquantificationtheremightbea needforaspeciesspecificstandardcurveasnumberofgenecopies varybetweenspecies(Weiratheretal.,2011),thusmakingthose assayslittlesuitableforauniversalquantitativeLeishmania-assay.

LiketheAAP3-Assay,theassayof(Wortmannetal.,2001),targeting theLeishmania16SrRNA,wasalsoabletoamplifyawiderangeof Leishmaniastrainsatthegenuslevel.However,thesensitivitywas onlydeterminedforL.(L.)mexicana,theCq-valuesbothwithinand betweenspecieshadagreatrange,thoughtheynotclearlyspec- ifyifthesameamountofDNAwasused,andparametersforassay performance,likeefficiency,LOQ,reproducibilityandrepeatability wasnotestimated,oratleastnotgiveninthetext.

ThechromosomethathoststheAAP3geneissupernumerary;

tetrasomicforsomespecies,likeL.(L.)major,L.(L.)infantumand L.(L.)donovani,andhexasomicforL.(V.)braziliensis(Rogersetal., 2011).InL.(L.)major,L.(L.)infantum,L.(V.)amazonensisandL.(L.) donovanitherearetwoidenticalcopiesofAAP3(Castilho-Martins etal.,2011;Shaked-Mishanetal.,2006),whereasinL.(L.)mex- icanathereisnoreportedequivalentgeneduplication.Wehave included22Leishmaniastrains, representing9differentspecies.

TheCq-valuesforthesestrainsusing100pgDNAastemplatein theAAP3-Assayareshownin Table1.Thereisvery littleintra- species variation in Cq-value, but some inter-species variation, mainlybetweenL.(V.)braziliensisandL.(V.)guyanensisagainstthe othersspeciesincludedinourstudy.Thismightindicatethatploidy betweenstrainsandspeciesdoesnotlargelyaffecttheresultsof theassay,butthisshouldbeinvestigatedfurther.Tupperwaretal.

(2008)describesaPCRassaytargetingtheLeishmaniaGP63able toamplifyseveraldifferentspecies, butcomparedtotheAAP3- AssaythereisamarkedlydifferenceintheCq-valuablebetween specieswhenthesameamountof templatewasused.Whether thereisaneedforaspeciesspecific,orevenstrainspecific,standard curvefortheAAP3-assaydependsonthespecificapplicationand therequiredaccuracy,andhasyettobemorethoroughlyevalu- ated.IncontrasttoothermulticopygeneslikethekDNAminicircle andITS1,withcopynumbersaround10000and200respectively, andasseenfromTable1,itislesslikely,andforseveralspecies probablyspeciesgroup-specificstandardcurvewillbesufficient.

Awayofavoiding aspeciesspecificstandard curvecouldbeto usetheDNAconcentrationsforthedilutionsofthestandardcurve insteadofthenumberofparasites,andthenusingspeciesrelated conversionfactors.

InthisstudywedevelopedaqPCRassaythatcanbeappliedon abroadrangeofspeciesoftheLeishmaniagenus,fromboththe Old-andNewWorldgroups,includingboth L.(Leishmania)spp.

andL.(Viannia)spp.,andwhichinadditioncanbeusedtoanalyze DNAfrombothcellculturesandmousetissue,andmostlikelyDNA fromseveralotherkindsofsamplematerials.Byusingastandard curveonecandeterminetheamountoftargetDNAinasample, and fromthatalsocalculatethenumber ofparasites. However, whenisolatingDNAfrominfectedtissuestheamountofDNAwill bedependentonthesizeofthetissuesampleandtherecovery ofDNAatthedifferentstepsoftheisolationprotocol.Theuseof hostreferencegenecancircumventthisproblem.Whenapplied toLeishmaniainfectedmouse,theAAP3-andTfrc-Assaysgivea ratiobetweenLeishmaniaDNAandmouseDNA.Thisratio,which isindependentoftheamountoftotalDNAappliedfortheanaly- sis,isreflectingparasiteloadinthetissueandhencedifferences canbedetected.InastudybyTupperwaretal.(2008),theynor- malizedtheparasitenumbertothetotalDNAisolatedfromthe micetissuesamples,andfinallyreportedtheparasitenumberper milligramoforiginaltissue,notusingahostreferencegene.This reportedresultcouldthenbepronetodifferencesinrecoveryof DNAduringtheextractionprocess.Nicolasetal.(2002)describe a real-time PCR assay which successfully detects four different Leishmaniaspeciesfromawiderangeofmouseinfectedtissues.

However,thestudydoesnotincludeamethod,likeusingahost referencegene,forestimatingandnormalizationoftheparasite burdenofthetissue.Theyalsotargetthehighcopynumbermini- circlekDNA,whichmighthavedrawbacks,asmentioned above.

Alimitationofourmethodisthatitnotnecessarilydiscriminates betweenliveanddeadparasites.However,thelevelsofLeishmania DNAdetectedwillstillindicatetheparasiteloadatthetimeof sampling.

Insummary,wehave developedaverysensitivemethodfor detectionofLeishmaniathatcanbeappliedforseveraldifferent speciesoftheparasite.Incombinationwithanassayforquantifica- tionofhostDNA,itispossibletomeasuretheloadofLeishmaniain infectedtissues.Withitshighsensitivitythemethodhaspotential asatoolfordiagnosticpurposes,includingdetectingasymptomatic infections.Duetothequantificationpossibility,themethodcanbe usedtomonitortheprogressofinfection,whichwillbeavaluable toolintestingnewdrugsandinvaccinedevelopment.

Acknowledgements

WearegratefultoSteinarSørnesattheDepartmentofClin- icalScience,University of Bergen,Bergen,Norway,for valuable technical assistance. The study was supported by the National

(6)

CentreforTropicalInfectiousDiseases,DepartmentofMedicine, HaukelandUniversityHospital,Bergen,Norway.

References

Alvar,J.,Velez,I.D.,Bern,C.,Herrero,M.,Desjeux,P.,Cano,J.,Jannin,J.,denBoer,M., 2012.WHOLeishmaniasisControlTeam,Leishmaniasisworldwideandglobal estimatesofitsincidence.PLoSOne7,e35671.

Aviles,H.,Belli,A.,Armijos,R.,Monroy,F.P.,Harris,E.,1999.PCRdetectionandiden- tificationofLeishmaniaparasitesinclinicalspecimensinEcuador:acomparison withclassicaldiagnosticmethods.J.Parasitol.85,181–187.

Bensoussan,E.,Nasereddin,A.,Jonas,F.,Schnur,L.F.,Jaffe,C.L.,2006.Comparison ofPCRassaysfordiagnosisofcutaneousleishmaniasis.J.Clin.Microbiol.44, 1435–1439.

Berzunza-Cruz,M.,Bricaire,G.,SalaizaSuazo,N.,Perez-Montfort,R.,Becker,I.,2009.

PCRforidentificationofspeciescausingAmericancutaneousleishmaniasis.

Parasitol.Res.104,691–699.

Bossolasco,S.,Gaiera,G.,Olchini,D.,Gulletta,M.,Martello,L.,Bestetti,A.,Bossi, L.,Germagnoli,L.,Lazzarin,A.,Uberti-Foppa,C.,Cinque,P.,2003.Real-time PCRassayforclinicalmanagementofhumanimmunodeficiencyvirus-infected patientswithvisceralleishmaniasis.J.Clin.Microbiol.41,5080–5084.

Britto,C.,Ravel,C.,Bastien,P.,Blaineau,C.,Pages,M.,Dedet,J.P.,Wincker,P.,1998.

Conservedlinkagegroupsassociatedwithlarge-scalechromosomalrearrange- mentsbetweenOldWorldandNewWorldLeishmaniagenomes.Gene222, 107–117.

Castilho-Martins,E.A.,LaranjeiradaSilva,M.F.,dosSantos,M.G.,Muxel,S.M.,Floeter- Winter,L.M.,2011.AxenicLeishmaniaamazonensispromastigotessenseboththe externalandinternalargininepooldistinctlyregulatingthetwotransporter- codinggenes.PLoSOne6,e27818.

Castilho,T.M.,Camargo,L.M.,McMahon-Pratt,D.,Shaw,J.J.,Floeter-Winter,L.M., 2008.Areal-timepolymerasechainreactionassayfortheidentificationand quantification ofAmerican Leishmania species onthe basis of glucose-6- phosphatedehydrogenase.Am.J.Trop.Med.Hyg.78,122–132.

deAlmeida,M.E.,Steurer,F.J.,Koru,O.,Herwaldt,B.L.,Pieniazek,N.J.,daSilva,A.J., 2011.IdentificationofLeishmaniaspp.bymolecularamplificationandDNA sequencinganalysisofafragmentofrRNAinternaltranscribedspacer2.J.Clin.

Microbiol.49,3143–3149.

deMonbrison,F.,Mihoubi,I.,Picot,S.,2007.Real-timePCRassayfortheidentification ofcutaneousLeishmaniaparasitespeciesinConstantineregionofAlgeria.Acta Trop.102,79–83.

Dymond,J.S.,2013.Explanatorychapter:quantitativePCR.MethodsEnzymol.529, 279–289.

Francino,O.,Altet,L.,Sanchez-Robert,E.,Rodriguez,A.,Solano-Gallego,L.,Alberola, J.,Ferrer,L.,Sanchez,A.,Roura,X.,2006.Advantagesofreal-timePCRassayfor diagnosisandmonitoringofcanineleishmaniosis.Vet.Parasitol.137,214–221.

Gomes,L.I.,Gonzaga,F.M.,deMorais-Teixeira,E.,deSouza-Lima,B.S.,Freire,V.V., Rabello,A.,2012.Validationofquantitativereal-timePCRfortheinvitroassess- mentofantileishmanialdrugactivity.Exp.Parasitol.131,175–179.

Harris,E.,Kropp,G.,Belli,A.,Rodriguez,B.,Agabian,N.,1998.Single-stepmulti- plexPCRassayforcharacterizationofNewWorldLeishmaniacomplexes.J.Clin.

Microbiol.36,1989–1995.

LeishmaniasisEpidemiologyNetworkSouthAmerica,2009.ManualMolecular Procedures.InstitutoOswaldoCruz,RiodeJaneiro,Brazil.

Mary,C.,Faraut,F.,Drogoul,M.P.,Xeridat,B.,Schleinitz,N.,Cuisenier,B.,Dumon,H., 2006.ReferencevaluesforLeishmaniainfantumparasitemiaindifferentclinical presentations:quantitativepolymerasechainreactionfortherapeuticmonitor- ingandpatientfollow-up.Am.J.Trop.Med.Hyg.75,858–863.

Mathers,C.D.,Ezzati,M.,Lopez,A.D.,2007.Measuringtheburdenofneglectedtrop- icaldiseases:theglobalburdenofdiseaseframework.PLoSNeglect.Trop.D1, e114.

Mohammadiha,A.,Mohebali,M.,Haghighi,A.,Mahdian,R.,Abadi,A.R.,Zarei,Z., Yeganeh,F.,Kazemi,B.,Taghipour,N.,Akhoundi,B.,2013.Comparisonofreal- timePCRandconventionalPCRwithtwoDNAtargetsfordetectionofLeishmania (Leishmania)infantuminfectioninhumananddogbloodsamples.Exp.Parasitol.

133,89–94.

Nicolas,L.,Prina,E.,Lang,T.,Milon,G.,2002.Real-timePCRfordetectionandquan- titationofLeishmaniainmousetissues.J.Clin.Microbiol.40,1666–1669.

Odiwuor,S.O.,Saad,A.A.,DeDoncker,S.,Maes,I.,Laurent,T.,ElSafi,S.,Mbuchi,M., Buscher,P.,Dujardin,J.C.,VanderAuwera,G.,2011.UniversalPCRassaysforthe differentialdetectionofallOldWorldLeishmaniaspecies.Eur.J.Clin.Microbiol., 209–218.

Pourabbas,B.,GhadimiMoghadam,A.,Pouladfar,G.,Rezaee,Z.,Alborzi,A.,2013.

Quantification ofLeishmaniainfantum kinetoplastDNA formonitoringthe responsetomeglumineantimoniatetherapyinvisceralleishmaniasis.Am.J.

Trop.Med.Hyg.88,868–871.

Prina,E.,Roux,E.,Mattei,D.,Milon,G.,2007.LeishmaniaDNAisrapidlydegraded followingparasitedeath:ananalysisbymicroscopyandreal-timePCR.Microbes Infect.9,1307–1315.

Quinnell,R.J.,Courtenay,O.,2009.Transmission,reservoirhostsandcontrolof zoonoticvisceralleishmaniasis.Parasitology136,1915–1934.

Rogers,M.B.,Hilley,J.D.,Dickens,N.J.,Wilkes,J.,Bates,P.A.,Depledge,D.P.,Harris, D.,Her,Y.,Herzyk,P.,Imamura,H.,Otto,T.D.,Sanders,M.,Seeger,K.,Dujardin, J.C.,Berriman,M.,Smith,D.F.,Hertz-Fowler,C.,Mottram,J.C.,2011.Chromosome andgenecopynumbervariationallowmajorstructuralchangebetweenspecies andstrainsofLeishmania.GenomeRes.21,2129–2142.

Shaked-Mishan,P.,Suter-Grotemeyer,M.,Yoel-Almagor,T.,Holland,N.,Zilberstein, D.,Rentsch,D.,2006.Anovelhigh-affinityargininetransporterfromthehuman parasiticprotozoanLeishmaniadonovani.Mol.Microbiol.60,30–38.

Srivastava,P.,Dayama,A.,Mehrotra,S.,Sundar,S.,2011a.Diagnosisofvisceralleish- maniasis.T.Roy.Soc.Trop.Med.H.105,1–6.

Srivastava,P.,Mehrotra,S.,Tiwary,P.,Chakravarty,J.,Sundar,S.,2011b.Diagnosis ofIndianvisceralleishmaniasisbynucleicaciddetectionusingPCR.PLoSOne6, e19304.

Sundar,S.,Chakravarty,J.,2013.Leishmaniasis:anupdateofcurrentpharmacothe- rapy.ExpertOpin.Pharmacol.14,53–63.

Talmi-Frank,D.,Nasereddin,A.,Schnur,L.F.,Schonian,G.,Toz,S.O.,Jaffe,C.L.,Baneth, G.,2010.DetectionandidentificationofoldworldLeishmaniabyhighresolution meltanalysis.PLoSNeglect.Trop.D4,e581.

Tupperwar,N.,Vineeth,V.,Rath,S.,Vaidya,T.,2008.Developmentofareal-time polymerasechainreactionassayforthequantificationofLeishmaniaspecies andthemonitoringofsystemicdistributionofthepathogen.Diagn.Micr.Infec.

Dis.61,23–30.

Wall,E.C.,Watson,J.,Armstrong,M.,Chiodini,P.L.,Lockwood,D.N.,2012.Epidemi- ologyofimportedcutaneousleishmaniasisattheHospitalforTropicalDiseases, London,UnitedKingdom:useofpolymerasechainreactiontoidentifythe species.Am.J.Trop.Med.Hyg.86,115–118.

Weirather,J.L.,Jeronimo,S.M.,Gautam,S.,Sundar,S.,Kang,M.,Kurtz,M.A.,Haque,R., Schriefer,A.,Talhari,S.,Carvalho,E.M.,Donelson,J.E.,Wilson,M.E.,2011.Serial quantitativePCRassayfordetection,speciesdiscrimination,andquantification ofLeishmaniaspp.inhumansamples.J.Clin.Microbiol.49,3892–3904.

WorldHealthOrganization,2010.Controloftheleishmaniases,WHOTechnical reportseries;no,949,Switzerland.

Wortmann,G.,Sweeney,C.,Houng,H.S.,Aronson,N.,Stiteler,J.,Jackson,J.,Ock- enhouse,C.,2001.Rapiddiagnosisofleishmaniasisbyfluorogenicpolymerase chainreaction.Am.J.Trop.Med.Hyg.65,583–587.

Wortmann,G.,Hochberg,L.,Houng,H.H.,Sweeney,C.,Zapor,M.,Aronson,N.,Weina, P.,Ockenhouse,C.F.,2005.RapididentificationofLeishmaniacomplexesbya real-timePCRassay.Am.J.Trop.Med.Hyg.73,999–1004.

Yang,S.,Rothman,R.E.,2004.PCR-baseddiagnosticsforinfectiousdiseases:uses, limitations,andfutureapplicationsinacute-caresettings.LancetInfect.Dis.4, 337–348.

Referanser

RELATERTE DOKUMENTER

Adipose Depots of KYNA-Treated Mice Reveal Gene Expression Signatures of Anti-inflammatory Immune Cells A–C Volcano plots for analysis of gene expression by quantitative real-time

There had been an innovative report prepared by Lord Dawson in 1920 for the Minister of Health’s Consultative Council on Medical and Allied Services, in which he used his

Figure 5.3 Measured time series of the pressure for HK 416 N at two different directions from the shooting direction, with and without flash suppressor, at 84 cm from the muzzle..

Azzam’s own involvement in the Afghan cause illustrates the role of the in- ternational Muslim Brotherhood and the Muslim World League in the early mobilization. Azzam was a West

To determine the detonation pressure we used the same charges as for detonation velocity measurement to perform the Plate Dent test.. In addition have we performed theoretical

The data for this thesis has consisted of the burial site at Borre and documents and reports from the 1988-1992 Borre Project, including field journals (Elliot, 1989; Forseth, 1991b,

Basal fossil forms (Eoverrucidae) possessed additional imbricating peduncular plates surrounding the wall, and Gale (2014b) recently gave an account of how the Verrucomorpha evolved

Objective: To investigate if there are differences in the changes in the lipid profile between weight stable, non-statin treated NW (BMI < 25 kg/m 2 ) and subjects with OB